Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Intellia Therapeutics Inc., 3 years.
Intellia Therapeutics Inc.
Director
GRAIL Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Intellia Therapeutics Inc. June 11, 202597.8%
-
GRAIL Inc. May 29, 202593.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 15, 2026 | GRAIL Inc. | Grant or award | +276 | $74.36 | $20,523 |
| Jun 18, 2026 | GRAIL Inc. | Grant or award | +5,491 | $63.74 | $349,996 |
| Jun 9, 2026 | Intellia Therapeutics Inc. | Grant or award | +9,200 | — | — |
| Apr 15, 2026 | GRAIL Inc. | Grant or award | +408 | $49.79 | $20,314 |
| Jan 15, 2026 | GRAIL Inc. | Grant or award | +213 | $97.44 | $20,755 |
| Oct 15, 2025 | GRAIL Inc. | Grant or award | +275 | $75.52 | $20,768 |
| Aug 20, 2025 | Intellia Therapeutics Inc. | Open-market purchase | +100,000 | $10.03 | $1,003,000 |
| Jul 15, 2025 | GRAIL Inc. | Grant or award | +533 | $38.53 | $20,536 |
| Jun 11, 2025 | Intellia Therapeutics Inc. | Grant or award | +8,000 | — | — |
| May 29, 2025 | GRAIL Inc. | Grant or award | +6,082 | $41.10 | $249,970 |
| Apr 15, 2025 | GRAIL Inc. | Grant or award | +784 | $25.94 | $20,337 |
| Jan 15, 2025 | GRAIL Inc. | Grant or award | +1,182 | $17.58 | $20,780 |
| Oct 30, 2024 | GRAIL Inc. | Grant or award | +210 | $13.62 | $2,860 |
| Oct 15, 2024 | GRAIL Inc. | Grant or award | +1,054 | $14.01 | $14,767 |
| Jun 25, 2024 | GRAIL Inc. | Grant or award | +26,470 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.